Announced Wed, 9 Sept · 22:50 IST
RPGAP subsidiary raises INR 243.33 crore from ILSF and Vistaject
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹2796.10
prior close
₹2789.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-1.0-0.7-0.6-3.6-0.9-2.0+0.6-0.2—————
Up moveDown movePending
AI summary
Wholly owned subsidiary RPG Active Pharma Limited (RPGAP) allotted securities to India Life Sciences Fund IV (ILSF) and Vistaject Fund (VJF) for INR 243.33 crores, giving them 40% stake. RPGAP stays a subsidiary of RPG Life Sciences. This follows an Investment and Shareholders Agreement signed on July 29, 2026.
Likely market impact
Subsidiary gets INR 243 crore growth capital; parent dilutes 40% but retains control. Generally positive for valuation and expansion plans.